Study population
The study prospectively included 202 consecutive patients with severe,
symptomatic AS undergoing TAVR at Gemelli Molise Hospital in Campobasso
and at Monaldi Hospital in Naples, from February 2017 to June 2021.
Patients requiring PPI before TAVR (n=23) were excluded, resulting in a
group of 179 patients.